Muscle phenotype in patients with myotonic dystrophy type 1

Muscle and Nerve

Volumn 47, Issue 3, 2013, Pages 409-415

  Andersen, Grete ^a   Ørngreen, Mette C ^a   Preisler, Nicolai ^a   Colding Jrgensen, Eskild ^a   Clausen, Torben ^b   Duno, Morten ^a   Jeppesen, Tina D ^a   Vissing, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Myotonia; Myotonic dystrophy type 1; Na+ K+ pump content; Phenotype; Vastus lateralis muscle biopsy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYTOSINE; GUANINE; MEXILETINE; THYMINE;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA STRUCTURE; DYNAMOMETRY; FEMALE; HAND GRIP; HISTOPATHOLOGY; HUMAN; MALE; MORPHOLOGY; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGING; BINDING SITES; BIOPSY; ELECTROMYOGRAPHY; FEMALE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOTONIA; MYOTONIC DYSTROPHY; OUABAIN; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84874240642     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23535     Document Type: Article

References (29)

1. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18.
2. Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 2004;74:793-804.
3. Zatz M, Passos-Bueno MR, Cerqueira A, Marie SK, Vainzof M, Pavanello RC. Analysis of the CTG repeat in skeletal muscle of young and adult myotonic dystrophy patients: when does the expansion occur? Hum Mol Genet 1995;4:401-406.
4. Tohgi H, Kawamorita A, Utsugisawa K, Yamagata M, Sano M. Muscle histopathology in myotonic dystrophy in relation to age and muscular weakness. Muscle Nerve 1994;17:1037-1043.
5. Thornell LE, Lindstom M, Renault V, Klein A, Mouly V, Ansved T, et al. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Neuropathol Appl Neurobiol 2009;35:603-613.
6. Dubowitz V, Sewry CA. Muscular dystrophies and allied disorders. V: Facioscapulohumeral, myotonic and oculopharygeal muscular dystrophy. In: Houston MJ, Cook L, editors. Muscle biopsy: a practical approach. Vol. 3. London: Elsevier; 2007. p 395-406.
7. Desnuelle C, Lombet A, Serratrice G, Lazdunski M. Sodium channel and sodium pump in normal and pathological muscles from patients with myotonic muscular dystrophy and lower motor neuron impairment. J Clin Invest 1982;69:358-367.
8. Clausen T. Na+-K+pump regulation and skeletal muscle contractility. Physiol Rev 2003;83:1269-1324.
9. Benders AA, Wevers RA, Veerkamp JH. Ion transport in human skeletal muscle cells: disturbances in myotonic dystrophy and Brody's disease. Acta Physiol Scand 1996;156:355-367.
10. Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001;56:336-340.
11. Brinkmann JR. Comparison of a hand-held and fixed dynamometer in measuring strength of patients with neuromuscular disease. J Orthop Sports Phys Ther 1994;19:100-104.
12. Moxley RT III, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT, et al. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1). Muscle Nerve 2007;36:320-328.
13. Logigian EL, Blood CL, Dilek N, Martens WB, Moxley RT, Wiegner AW, et al. Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1. Muscle Nerve 2005;32:35-42.
14. Colding-Jorgensen E, Duno M, Schwartz M, Vissing J. Decrement of compound muscle action potential is related to mutation type in myotonia congenita. Muscle Nerve 2003;27:449-455.
15. Dubowitz V, Sewry CA. Definition of pathological changes seen in muscle biopsies. In: Houston MJ, Cook L, editors. Muscle biopsy: a practical approach. Vol. 3. London: Elsevier; 2007. p 75-124.
16. Clausen T. Clinical and therapeutic significance of the Na+, K+pump. Clin Sci Lond 1998;95:3-17.
17. Arsenault ME, Prevost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006;66:1248-1250.
18. Hedberg B, Anvret M, Ansved T. CTG-repeat length in distal and proximal leg muscles of symptomatic and non-symptomatic patients with myotonic dystrophy: relation to muscle strength and degree of histopathological abnormalities. Eur J Neurol 1999;6:341-346.
19. Leshner RT. Genotype-phenotype correlations in hereditary muscle diseases. Implications for diagnosis and treatment. Suppl Clin Neurophysiol 2004;57:322-333.
20. Logigian EL, Moxley RT, Blood CL, Barbieri CA, Martens WB, Wiegner AW, et al. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. Neurology 2004;62:1081-1089.
21. Salehi LB, Bonifazi E, Stasio ED, Gennarelli M, Botta A, Vallo L, et al. Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2, 650 patients. Genet Test 2007;11:84-90.
22. Salvatori S, Fanin M, Trevisan CP, Furlan S, Reddy S, Nagy JI, et al. Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1. Neurol Sci 2005;26:235-242.
23. Savic D, Rakocvic-Stojanovic V, Keckarevic D, Culjkovic B, Stojkovic O, Mladenovic J, et al. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1. Hum Mutat 2002;19:131-139.
24. Lexell J, Taylor CC. Variability in muscle fibre areas in whole human quadriceps muscle: effects of increasing age. J Anat 1991;174:239-249.
25. Ørngreen MC, Arlien-Sborg P, Duno M, Hertz JM, Vissing J. Endocrine function in 97 patients with myotonic dystrophy type 1. J Neurol 2012;97:E765-770.
26. Orngreen MC, Olsen DB, Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol 2005;57:754-757.
27. Tollback A, Eriksson S, Wredenberg A, Jenner G, Vargas R, Borg K, et al. Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med 1999;31:9-16.
28. Torres C, Moxley RT, Griggs RC. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy. J Neurol Sci 1983;60:157-168.
29. Michel P, Sternberg D, Jeannet PY, Dunand M, Thonney F, Kress W, et al. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders. Muscle Nerve 2007;36:643-650.